Mary E Gaffield

Summary

Affiliation: World Health Organization
Country: Switzerland

Publications

  1. ncbi request reprint Medical eligibility criteria for new contraceptive methods: combined hormonal patch, combined hormonal vaginal ring and the etonogestrel implant
    Mary E Gaffield
    Department of Reproductive Health and Research, World Health Organization, CH 1211 Geneva 27, Switzerland
    Contraception 73:134-44. 2006
  2. doi request reprint Use of combined oral contraceptives post abortion
    Mary E Gaffield
    Department of Reproductive Health and Research, World Health Organization, Geneva, 27, Switzerland
    Contraception 80:355-62. 2009
  3. doi request reprint Combined oral contraceptive and intrauterine device use among women with gestational trophoblastic disease
    Mary E Gaffield
    Department of Reproductive Health and Research, World Health Organization, 1211 Geneva 27, Switzerland
    Contraception 80:363-71. 2009
  4. doi request reprint Oral contraceptives and family history of breast cancer
    Mary E Gaffield
    Department of Reproductive Health and Research, World Health Organization, 1211 Geneva 27, Switzerland
    Contraception 80:372-80. 2009
  5. doi request reprint The use of hormonal contraception among women taking anticonvulsant therapy
    Mary E Gaffield
    Department of Reproductive Health and Research, World Health Organization, 1211 Geneva, 27 Switzerland
    Contraception 83:16-29. 2011
  6. doi request reprint Initiation of progestogen-only injectables on different days of the menstrual cycle and its effect on contraceptive effectiveness and compliance: a systematic review
    Nathalie Kapp
    Department of Reproductive Health and Research, World Health Organization, Geneva CH 1211, Switzerland
    Contraception 87:576-82. 2013
  7. doi request reprint Risk of venous thromboembolism during the postpartum period: a systematic review
    Emily Jackson
    Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland
    Obstet Gynecol 117:691-703. 2011
  8. doi request reprint Pregnancy outcomes with an IUD in situ: a systematic review
    Dalia Brahmi
    Department of Reproductive Health and Research, World Health Organization, CH 1211 Geneva 27, Switzerland
    Contraception 85:131-9. 2012
  9. ncbi request reprint Effective use of hormonal contraceptives: Part II: Combined hormonal injectables, progestogen-only injectables and contraceptive implants
    Camaryn E Chrisman
    Wake Forest University School of Medicine, Winston Salem, NC 27157, USA
    Contraception 73:125-33. 2006

Detail Information

Publications9

  1. ncbi request reprint Medical eligibility criteria for new contraceptive methods: combined hormonal patch, combined hormonal vaginal ring and the etonogestrel implant
    Mary E Gaffield
    Department of Reproductive Health and Research, World Health Organization, CH 1211 Geneva 27, Switzerland
    Contraception 73:134-44. 2006
    ..Limited evidence also suggests no adverse effects of the etonogestrel implant on lactation parameters or infant development among users enrolled 28 to 56 days postpartum and followed for 4 months...
  2. doi request reprint Use of combined oral contraceptives post abortion
    Mary E Gaffield
    Department of Reproductive Health and Research, World Health Organization, Geneva, 27, Switzerland
    Contraception 80:355-62. 2009
    ..Providing combined oral contraceptives (COCs) following surgical or medical induced abortion offers women an opportune moment to initiate a reliable contraceptive method...
  3. doi request reprint Combined oral contraceptive and intrauterine device use among women with gestational trophoblastic disease
    Mary E Gaffield
    Department of Reproductive Health and Research, World Health Organization, 1211 Geneva 27, Switzerland
    Contraception 80:363-71. 2009
    ..Women diagnosed with gestational trophoblastic disease (GTD) need safe and effective contraception because they are advised to delay a subsequent pregnancy...
  4. doi request reprint Oral contraceptives and family history of breast cancer
    Mary E Gaffield
    Department of Reproductive Health and Research, World Health Organization, 1211 Geneva 27, Switzerland
    Contraception 80:372-80. 2009
    ..Questions remain regarding whether oral contraceptive (OC) use among women with a family history of breast cancer increases disease risk...
  5. doi request reprint The use of hormonal contraception among women taking anticonvulsant therapy
    Mary E Gaffield
    Department of Reproductive Health and Research, World Health Organization, 1211 Geneva, 27 Switzerland
    Contraception 83:16-29. 2011
    ..Drug interactions between hormonal contraceptives and anticonvulsants, resulting in reduced contraceptive effectiveness and/or increased seizure activity, have been published...
  6. doi request reprint Initiation of progestogen-only injectables on different days of the menstrual cycle and its effect on contraceptive effectiveness and compliance: a systematic review
    Nathalie Kapp
    Department of Reproductive Health and Research, World Health Organization, Geneva CH 1211, Switzerland
    Contraception 87:576-82. 2013
    ..Our objective was to determine from the literature when a woman can initiate progestogen-only injectables for contraception...
  7. doi request reprint Risk of venous thromboembolism during the postpartum period: a systematic review
    Emily Jackson
    Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland
    Obstet Gynecol 117:691-703. 2011
    ..To determine, from the literature, the risk of venous thromboembolism during the postpartum period...
  8. doi request reprint Pregnancy outcomes with an IUD in situ: a systematic review
    Dalia Brahmi
    Department of Reproductive Health and Research, World Health Organization, CH 1211 Geneva 27, Switzerland
    Contraception 85:131-9. 2012
    ..The objective of this systematic review is to assess the evidence about risks for adverse pregnancy outcomes among women who conceive with an IUD in situ...
  9. ncbi request reprint Effective use of hormonal contraceptives: Part II: Combined hormonal injectables, progestogen-only injectables and contraceptive implants
    Camaryn E Chrisman
    Wake Forest University School of Medicine, Winston Salem, NC 27157, USA
    Contraception 73:125-33. 2006
    ..Norplant implants left in place for up to seven completed years remained effective among women who weighed <70 kg at the time of implant insertion, but their effectiveness decreased among women weighing >or=70 kg...